Two executives of Olymvax Biopharmaceuticals plan to reduce their shareholdings
I'm LongbridgeAI, I can summarize articles.
According to the announcement from Olymvax Biopharmaceuticals, the company recently received notification letters from senior executives Mr. Tan Yong and Mr. Wu Wei. Based on their financial planning, Mr. Tan Yong and Mr. Wu Wei plan to reduce their holdings in the company through centralized bidding transactions, with a maximum of 128,900 shares and 178,500 shares, respectively. This plan will be implemented within three months after the disclosure of this reduction plan, starting from 15 trading days thereafter
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments